Focus on CNS conformational diseases and oncology, using a combination of antibodies produced to non-covalent complexes of peptide sequences, presented as liposomes. Technical and corporate overviews of company in Lausanne, Switzerland.

Researches and develops novel therapeutic and diagnostic products to treat chronic debilitating diseases such as cancer, central nervous system disorders and autoimmune diseases. Based in Massachusetts. (Nasdaq: BLSI).

Company developing gene therapy system, using the E. coli enzyme, purine nucleoside phosphorylase, to induce suicide in tumor cells. Includes technology background, research, patents, publications, key staff, and contacts in Birmingham, Alabama.